FDA's regulation of the marketing of unapproved new drugs : the case of E-Ferol vitamin E aqueous solution : hearing before a subcommittee of the Committee on Government Operations, House of Representatives, Ninety-eighth Congress, second session, May 4, 1984.

FDA's regulation of the marketing of unapproved new drugs : the case of E-Ferol vitamin E aqueous solution : hearing before a subcommittee of the Committee on Government Operations, House of Representatives, Ninety-eighth Congress, second session, May 4, 1984.

Saved in:

Bibliographic Details
Corporate Author:	United States. Congress. House. Committee on Government Operations. Intergovernmental Relations and Human Resources Subcommittee (Author)
Format:	Electronic eBook
Language:	English
Published:	Washington : U.S. Government Printing Office, 1984.
Series:	U.S. Congressional documents. Congressional hearings.
Subjects:	United States. > Food and Drug Administration. Vitamin E > Law and legislation > United States. Legislative hearings. Electronic books.
Online Access:	HeinOnline U.S. Congressional Documents Collection
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

FDA's regulation of the marketing of unapproved new drugs : the case of E-Ferol vitamin E aqueous solution : hearing before a subcommittee of the Committee on Government Operations, House of Representatives, Ninety-eighth Congress, second session, May 4, 1984
Published: (1984)

Vitamin A : an urgent nutritional need for the world's children /
by: Herbers, Mary Ruth
Published: (1985)

Vitamin A : an urgent nutritional need for the world's children /
by: Herbers, Mary Ruth
Published: (1985)

Vitamin, mineral, and diet supplements. Hearings, Ninety-third Congress, first session ...
Published: (1974)

Dietary supplements : commission report and FDA regulation /
by: Porter, Donna Viola
Published: (1998)

Access to unapproved drugs : FDA policies on compassionate use and emergency use authorization.
Published: (2015)

FDA regulation of the new drug "Serc". Hearing before a subcommittee of the Committee on Government Operations, House of Representatives, Ninety-second Congress, second session.
Published: (1972)

FDA's regulation of the new drug Versed : hearings before a subcommittee of the Committee on Government Operations, House of Representatives, One Hundredth Congress, second session, May 5 and 10, 1988.
Published: (1988)

FDA's regulation of the new drug Versed : hearings before a subcommittee of the Committee on Government Operations, House of Representatives, One Hundredth Congress, second session, May 5 and 10, 1988
Published: (1988)

FDA's regulation of the new drug Suprol : hearing before a subcommittee of the Committee on Government Operations, House of Representatives, One Hundredth Congress, first session, May 27, 1987.
Published: (1988)

FDA's regulation of the new drug Suprol : hearing before a subcommittee of the Committee on Government Operations, House of Representatives, One Hundredth Congress, first session, May 27, 1987
Published: (1988)

Food and Drug Administration (FDA) : overview and issues /
by: Williams, Erin D.
Published: (2008)

How FDA approves drugs and regulates their safety and effectiveness /
by: Bodie, Agata, et al.
Published: (2018)

How FDA approves drugs and regulates their safety and effectiveness /
by: Thaul, Susan
Published: (2012)

How FDA approves drugs and regulates their safety and effectiveness /
by: Thaul, Susan
Published: (2012)

How FDA approves drugs and regulates their safety and effectiveness.
Published: (2013)

FDA regulation of the new drug "Serc" : hearing before a subcommittee of the Committee on Government Operations, House of Representatives, Ninety-second Congress, second session. September 25, 1972.
Published: (1972)

FDA's authority to regulate drug compounding : a legal analysis /
by: Staman, Jennifer A.
Published: (2012)

FDA's regulation of the drug "triazure" : hearing before a Subcommittee of the Committee on Government Operations, House of Representatives, Ninety-fourth Congress, second session. October 27, 1976
Published: (1976)

Nomination : hearing of the Committee on Labor and Human Resources, United States Senate, One Hundred Fifth Congress, second session on Jane E. Henney, of New Mexico, to be Commissioner of Food and Drugs, Department of Health and Human Services, September 2, 1998.
Published: (1998)

Promotion of drugs and medical devices for unapproved uses : hearing before the Human Resources and Intergovernmental Relations Subcommittee of the Committee on Government Operations, House of Representatives, One Hundred Second Congress, first session, June 11, 1991
Published: (1992)

The safety and effectiveness of new drugs (marketing of fixed combination drugs and unapproved new drugs; implementation of drug efficacy findings) : hearing before a subcommittee of the Committee on Government Operations, House of Representatives, Ninety-second Congress, first session, May 26, 1971.
Published: (1971)

Export of unapproved drugs : hearing before the Subcommittee on Health and the Environment of the Committee on Energy and Commerce, House of Representatives, Ninety-ninth Congress, second session on H.R. 3962 and H.R. 3995, bills to amend the Federal Food, Drug, and Cosmetic Act to authorize the export of certain unapproved drugs, and for other purposes, April 28, 1986.
Published: (1986)

Man-in-the-plant--FDA's failure to regulate deceptive drug labeling : report, together with separate views /
Published: (1978)

FDA and drug prices : facilitating access to generic drugs /
by: Bodie, Agata
Published: (2019)

FDA regulation of over-the-counter (OTC) drugs : overview and issues for Congress /
by: Bodie, Agata
Published: (2021)

FDA's regulation of the drug "triazure" : hearing before a Subcommittee of the Committee on Government Operations, House of Representatives, Ninety-fourth Congress, second session. October 27, 1976.
Published: (1976)

Oversight of the new drug review process and FDA's regulation of Merital : hearing before a subcommittee of the Committee on Government Operations, House of Representatives, Ninety-ninth Congress, second session, May 22, 1986.
Published: (1987)

Oversight of the new drug review process and FDA's regulation of Merital : hearing before a subcommittee of the Committee on Government Operations, House of Representatives, Ninety-ninth Congress, second session, May 22, 1986
Published: (1987)

Modernizing FDA's regulation of over-the-counter drugs : hearing before the Subcommittee on Health of the Committee on Energy and Commerce, House of Representatives, One Hundred Fifteenth Congress, first session. September 13, 2017
Published: (2018)

Modernizing FDA's regulation of over-the-counter drugs : hearing before the Subcommittee on Health of the Committee on Energy and Commerce, House of Representatives, One Hundred Fifteenth Congress, first session. September 13, 2017.
Published: (2018)

FDA papers
Published: (1967)

Myths and facts about human growth hormone, B-12, and other substances : hearing before the Committee on Oversight and Government Reform, House of Representatives, One Hundred Tenth Congress, second session, February 12, 2008.
Published: (2009)

Myths and facts about human growth hormone, B-12, and other substances : hearing before the Committee on Oversight and Government Reform, House of Representatives, One Hundred Tenth Congress, second session, February 12, 2008
Published: (2009)

Promotion of drugs and medical devices for unapproved uses : hearing before the Human Resources and Intergovernmental Relations Subcommittee of the Committee on Government Operations, House of Representatives, One Hundred Second Congress, first session, June 11, 1991.
Published: (1992)

FDA's drug approval process : up to the challenge? : hearing of the Committee on Health, Education, Labor, and Pensions, United States Senate, One Hundred Ninth Congress, first session on examining Food and Drug Administration's (FDA) drug approval process, focusing on FDA's drug approval process after a sponsor demonstrates that their benefits outweigh their risks for a specific population and use, and that the drug meet meets standards for safety and efficacy, March 1, 2005.
Published: (2005)

FDA consumer protection activities--FDA reorganization. Hearings, Ninety-first Congress, first and second session ..
Published: (1970)

The FDA Commission : the delegation of authority to state and local authorities
Published: (1989)

The Food and Drug Administration (FDA) budget : fact sheet /
by: Bodie, Agata, et al.
Published: (2018)

Food and Drug Administration (FDA) budget : fact sheet /
by: Bodie, Agata, et al.
Published: (2016)